Actimis Pharmaceuticals
Latest round
- Series A
Last raised
- Apr 2005
Total raised
- $6M
Investors
- 2
About Actimis Pharmaceuticals
Actimis Pharmaceuticals specializes in domain name registration and transfer services. The company, founded by Kevin Bacon, is headquartered in San Diego, US. In June 2008, Boehringer Ingelheim acquired Actimis Pharmaceuticals.com primarily offers domain name registration and transfer services, focusing on the sale of premium domain names.com domain, available for purchase at a price point of USD 3,595. This service caters to businesses and individuals seeking to establish an online presence, enhance brand visibility, or secure valuable digital assets.com generates revenue primarily through direct sales of domain names, with transactions structured as one-time purchases. Clients engage in straightforward transactions where they pay USD 3,595 to acquire a domain, which includes additional support services such as secure payment processing and transaction assistance.com domain, is central to their revenue model, attracting a diverse clientele. The company is developing additional premium domain names aimed at enhancing brand visibility for businesses. They are looking to enter the European market more aggressively by the end of 2024.
Who invested in Actimis Pharmaceuticals
2 investors across 1 round
See all investors in Actimis Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 28, 2005
Amount
$6M
Investors
Questions about Actimis Pharmaceuticals
Who invested in Actimis Pharmaceuticals?
Actimis Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Actimis Pharmaceuticals raised?
Actimis Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Actimis Pharmaceuticals last raise money?
Actimis Pharmaceuticals's most recent round on record is a Series A, in Apr 2005.
What does Actimis Pharmaceuticals do?
Actimis Pharmaceuticals specializes in domain name registration and transfer services.
Where is Actimis Pharmaceuticals headquartered?
Actimis Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Actimis Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Actimis Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Actimis Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.